The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors.
about
Contribution of CXCL12 secretion to invasion of breast cancer cells.A natural ErbB4 isoform that does not activate phosphoinositide 3-kinase mediates proliferation but not survival or chemotaxisUnique carboxyl-terminal sequences of wild type and alternatively spliced variant forms of transforming growth factor-alpha precursors mediate specific interactions with ErbB4 and ErbB2Identification of a region within the ErbB2/HER2 intracellular domain that is necessary for ligand-independent associationMechanism of activation and inhibition of the HER4/ErbB4 kinaseSuppressors of cytokine signaling 4 and 5 regulate epidermal growth factor receptor signalingEpigen, the last ligand of ErbB receptors, reveals intricate relationships between affinity and mitogenicityTyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinasesDesigning a HER2/neu promoter to drive alpha1,3galactosyltransferase expression for targeted anti-alphaGal antibody-mediated tumor cell killing.Human epidermal growth factor receptor signaling in acute lung injuryProfile of neratinib and its potential in the treatment of breast cancerCoronary vasculature patterning requires a novel endothelial ErbB2 holoreceptorReceptor tyrosine kinase signaling: regulating neural crest development one phosphate at a timeSensitivity of mature Erbb2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90Development of a method for the purification and culture of rodent astrocytesThe ErbB4 receptor in fetal rat lung fibroblasts and epithelial type II cellsInsights into the evolution of the ErbB receptor family and their ligands from sequence analysisTreatment of vestibular schwannoma cells with ErbB inhibitorsSelection of peptides and synthesis of pentameric peptabody molecules reacting specifically with ErbB-2 receptor.Molecular mechanisms underlying endocytosis and sorting of ErbB receptor tyrosine kinases.Modeling ERBB receptor-regulated G1/S transition to find novel targets for de novo trastuzumab resistanceInput-output behavior of ErbB signaling pathways as revealed by a mass action model trained against dynamic dataErbB4-neuregulin signaling modulates synapse development and dendritic arborization through distinct mechanismsElimination of progressive mammary cancer by repeated administrations of chimeric antigen receptor-modified T cells.Ubiquitination and degradation of the thrombopoietin receptor c-Mpl.Structure and function of epigen, the last EGFR ligand.Artemin, a member of the glial cell line-derived neurotrophic factor family of ligands, is HER2-regulated and mediates acquired trastuzumab resistance by promoting cancer stem cell-like behavior in mammary carcinoma cells.ERBB3: A potential serum biomarker for early detection and therapeutic target for devil facial tumour 1 (DFT1)Human epidermal growth factor receptor 2 expression in urothelial carcinoma of the renal pelvis: correlation with clinicopathologic parametersRole of receptor tyrosine kinases and their ligands in glioblastoma.Mechanisms of activation of receptor tyrosine kinases: monomers or dimers.Hyperinsulinemia promotes metastasis to the lung in a mouse model of Her2-mediated breast cancer.Generation and characterization of peptide mimotopes specific for anti ErbB-2 monoclonal antibodies.Oncogenic mutant forms of EGFR: lessons in signal transduction and targets for cancer therapy.Coclustering of ErbB1 and ErbB2 revealed by FRET-sensitized acceptor bleaching.Tailored cancer immunotherapy using combinations of chemotherapy and a mixture of antibodies against EGF-receptor ligands.Understanding resistance to EGFR inhibitors-impact on future treatment strategiesDistribution of resting and ligand-bound ErbB1 and ErbB2 receptor tyrosine kinases in living cells using number and brightness analysisTargeted therapies in non-small cell lung cancer: emerging oncogene targets following the success of epidermal growth factor receptor.Polymersomes as an effective drug delivery system for glioma--a review.
P2860
Q22000754-A1C11C04-B561-424D-8FA2-61E648F6C6E6Q22253346-C6C40AB3-6D68-4F13-9C7E-208363333551Q22254700-2493A39B-2C5B-4428-A4B6-4CD6309FE373Q24297029-9D5F0B55-B70F-42B1-BF28-BA69A0E991E5Q24310089-693D247C-6463-4585-98F1-B0C3160D5B4DQ24321251-39AE0EDA-9229-4A69-9D87-16F715D5C292Q24324102-90D78353-EDD8-4DA1-BCCE-429AB14A47D4Q24802950-39C45A31-349D-469D-A583-F438ED45718FQ24810669-1F984F0A-77C4-4413-8AA2-A1F03A5C4450Q27002075-5DD08075-CBC6-4D5F-B84B-9ACC28684C3BQ27012540-FA7CBAC3-8843-4C70-8F47-52B896105F68Q27340378-5089A6A9-580C-4A43-BF3B-78EA250F8354Q28083779-362FE475-161F-43DF-8DE0-57C3166E7DF9Q28143497-4ED7D8A1-F320-4000-8A1A-8BF71DD10AF0Q28247536-B8335D6E-F978-487B-966C-6D8E4CFD28A3Q28564324-CE720AD3-A9E7-4D01-AF02-E902549FBDABQ28767062-BD15BB35-1D05-4E08-BB5D-D4CA8955320AQ30458767-9E75D0D5-07E2-4C10-96E1-9AEB7F30493EQ30988881-46D1889C-7362-4B38-B935-705A9B0C1413Q32062433-6717DF86-7007-4ED6-A67E-EA78606DB019Q33396832-EF844CEB-D5FE-463C-B522-E9E2DF24F575Q33401214-12ABA462-8154-40BE-894F-1BBBE41B80CCQ33574071-C29448C1-9BAC-4FA1-A32C-D9BB9B1AB83FQ33587034-3D4CE8D4-F963-4A1D-B002-5A6F54BD1BAFQ33677470-F3B40B56-860C-41CB-9F99-CA26B27C4C6AQ33680363-8F725D5D-CD23-45AF-A983-CCD9BA1251CAQ33718457-EA3A4B42-49BB-4B95-BA20-A64C1CEAF5F0Q33772914-7E4806E3-D534-4E05-824F-55AFADF3BE9CQ33802832-386A75BC-0029-4C27-95BD-E1CF02A3FD50Q33883849-B6C66AD0-10B1-4001-8C36-0D41BC440922Q33883884-F65C234D-6920-4C3C-90B8-9CD1A4C7B190Q33887610-1ACD7787-D750-4171-9699-98985A52255AQ33907971-72F56EC0-0338-471F-BCED-361866E8F696Q33943421-FC469B4B-505B-48D2-9D48-B7286AB0CEEBQ33954390-8E9C764D-B89F-437F-9788-1642415D47D1Q34005061-48E0163D-7B0D-4E39-8C36-BBD292157191Q34088424-3BFA290E-7245-46F2-9DC9-980714E63689Q34151773-1529E032-3450-4AA5-B409-2F875F2F54D2Q34158153-E68DF274-38D0-43F9-9D4F-A73309D0CEDFQ34420100-13DB85E3-C382-4B47-B47D-97628CB33640
P2860
The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
The ErbB-2/HER2 oncoprotein of ...... stroma-derived growth factors.
@ast
The ErbB-2/HER2 oncoprotein of ...... stroma-derived growth factors.
@en
type
label
The ErbB-2/HER2 oncoprotein of ...... stroma-derived growth factors.
@ast
The ErbB-2/HER2 oncoprotein of ...... stroma-derived growth factors.
@en
prefLabel
The ErbB-2/HER2 oncoprotein of ...... stroma-derived growth factors.
@ast
The ErbB-2/HER2 oncoprotein of ...... stroma-derived growth factors.
@en
P2093
P2860
P356
P1476
The ErbB-2/HER2 oncoprotein of ...... stroma-derived growth factors.
@en
P2093
G C Andrews
L N Klapper
P2860
P304
P356
10.1073/PNAS.96.9.4995
P407
P577
1999-04-01T00:00:00Z